HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Claude Deschamps Victor F. Trastek Peter C. Pairolero Mark S. Allen Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sawyer, T. E. Articles by Li, H. Search for Related Content PubMed PubMed Citation Articles by Sawyer, T. E. Articles by Li, H. Related Collections Related Article

Ann Thorac Surg 1997;64:1402-1407
© 1997 The Society of Thoracic Surgeons

---

Original Articles: General Thoracic

Effectiveness of Postoperative Irradiation in Stage IIIA Non–Small Cell Lung Cancer According to Regression Tree Analyses of Recurrence Risks

Divisions of Radiation Oncology, Thoracic Surgery, and Biostatistics, Mayo Clinic, Rochester, Minnesota

Background. In the setting of grossly resected stage IIIA (N2 involvement) non–small cell lung carcinoma, the role of adjuvant postoperative thoracic radiation therapy (TRT) remains controversial. This study was initiated to subcategorize these patients into high-, intermediate-, and low-risk groups with respect to local recurrence and survival rates, and to determine whether there were certain subgroups of patients who were particularly likely or unlikely to benefit from postoperative TRT.

Methods. Two hundred twenty-four patients were studied. A regression tree analysis was used to separate patients who had undergone operation alone into groups that had a high, intermediate, or low risk of local recurrence and death. The effect of adjuvant postoperative TRT then was examined in each of these groups.

Results. The use of adjuvant postoperative TRT (compared with operation alone) was associated with an improvement in freedom from local recurrence and survival for patients who had an intermediate or high risk of local recurrence and death. However, the greatest level of improvement in freedom from local recurrence (p < 0.0001) and survival (p = 0.0002) associated with the use of adjuvant postoperative TRT was in the high-risk group. Similarly, but of lesser magnitude, the intermediate-risk group had improved freedom from local recurrence and survival rates with the use of adjuvant postoperative TRT (p = 0.002 and p = 0.01, respectively). For the low-risk group, the freedom from local recurrence and survival rates were not statistically different between the patients who received adjuvant postoperative TRT and those who underwent observation.

Conclusions. Patients with non–small cell lung carcinoma involving ipsilateral mediastinal lymph nodes (stage IIIA) who undergo gross resection and who are at either high or intermediate risk for local recurrence and death are likely to benefit from adjuvant postoperative irradiation. The role of radiation therapy in low-risk patients is unclear. Prospective confirmation of these observations is warranted.

Related Article

Invited Commentary

David J. Girling
Ann. Thorac. Surg. 1997 64: 1407-1408. [Extract] [Full Text]

This article has been cited by other articles:

				A. J. Wozniak and S. M. Gadgeel Review: Adjuvant therapy for resected non-small cell lung cancer Therapeutic Advances in Medical Oncology, September 1, 2009; 1(2): 109 - 118. [Abstract] [PDF]

				H. Matsuguma, R. Nakahara, Y. Ishikawa, H. Suzuki, K. Inoue, S. Katano, and K. Yokoi Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 573 - 577. [Abstract] [Full Text] [PDF]

				B. E. Lally, D. Zelterman, J. M. Colasanto, B. G. Haffty, F. C. Detterbeck, and L. D. Wilson Postoperative Radiotherapy for Stage II or III Non-Small-Cell Lung Cancer Using the Surveillance, Epidemiology, and End Results Database J. Clin. Oncol., July 1, 2006; 24(19): 2998 - 3006. [Abstract] [Full Text] [PDF]

				J. A. Bonner and S. A. Spencer Postoperative Radiotherapy in Non--Small-Cell Lung Cancer Warrants Further Exploration in the Era of Adjuvant Chemotherapy and Conformal Radiotherapy J. Clin. Oncol., July 1, 2006; 24(19): 2978 - 2980. [Full Text] [PDF]

				J. A. Bogart and J. N. Aronowitz Localized Non-Small Cell Lung Cancer: Adjuvant Radiotherapy in the Era of Effective Systemic Therapy Clin. Cancer Res., July 1, 2005; 11(13): 5004s - 5010s. [Abstract] [Full Text] [PDF]

				E. Vallieres, M. Machtay, E. Glatstein, and J. A. Bonner Adjuvant Radiation Therapy After Complete Resection of Non-Small-Cell Lung Cancer J. Clin. Oncol., March 1, 2002; 20(5): 1427 - 1429. [Full Text] [PDF]

				J. A. Bonner, S. A. Tincher, and J. B. Fiveash Balancing the Possible Effectiveness of Postoperative Radiotherapy for Non-Small-Cell Lung Cancer Against the Possible Detriment of Radiation-Induced Toxicity J. Clin. Oncol., October 1, 2001; 19(19): 3905 - 3907. [Full Text]

				F. W. Grannis Jr A response to ""Clinical Trials in Lung Cancer: Truth, Justice, and the American Way"" Ann. Thorac. Surg., October 1, 2001; 72(4): 1438 - 1438. [Full Text] [PDF]

				J. H. Lee, M. Machtay, L. R. Kaiser, J. S. Friedberg, S. M. Hahn, M. G. McKenna, and W. G. McKenna Non-Small Cell Lung Cancer: Prognostic Factors in Patients Treated with Surgery and Postoperative Radiation Therapy Radiology, December 1, 1999; 213(3): 845 - 852. [Abstract] [Full Text]